Sarepta Therapeutics Inc.’s experimental drug to treat Ebola and Marburg showed no ill effects in an early-phase clinical study on healthy adult volunteers.
from WSJ.com: US Business http://ift.tt/102u16U
via IFTTT
from WSJ.com: US Business http://ift.tt/102u16U
via IFTTT
No comments:
Post a Comment